Baseline Characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)

Marc A. Pfeffer, Emmanuel A. Burdmann, Chao Yin Chen, Mark E. Cooper, Dick de Zeeuw, Kai Uwe Eckardt, Peter Ivanovich, Reshma Kewalramani, Andrew S. Levey, Eldrin F. Lewis, Janet McGill, John J V McMurray, Patrick Parfrey, Hans Henrik Parving, Giuseppe Remuzzi, Ajay K. Singh, Scott D. Solomon, Robert Toto, Hajime Uno

Research output: Contribution to journalArticlepeer-review

44 Scopus citations

Fingerprint Dive into the research topics of 'Baseline Characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT)'. Together they form a unique fingerprint.

Medicine & Life Sciences